Population Biomarker Studies
Population Biomarker Studies - Related Videos
07:20
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
0 Views •
Cited by 65 •
2014
Biomarkers are directly-measured biological indicators of disease or health. In population and social sciences, biomarkers need to be easy to obtain, transport, and analyze. Dried Blood Spot (DBS) collection meets this need, can be collected in the field with high response rates and analyzed for a variety of biomarkers.
08:29
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
0 Views •
Cited by 29 •
2012
We describe a rat model of post traumatic stress disorder (PTSD) that reveals the persistent alterations in neuroendocrine function and the delayed long-term, exaggerated fear response, characteristic of PTSD patients. The animal model and methods described here are useful for correlating biomarkers in brain nuclei, which are mechanistic but cannot be measured in patients, with biomarkers in peripheral white blood cells, which can.
04:45
Population Growth - Concepts
0 Views •
2019
Population Models An ecological population is a group of individuals of a single species living in an area at the same time. To persist, a population must either grow or maintain its size. Population ecology is the study of how population size and age distribution change over time through interactions with other species and the environment as well as with individuals of their own species. A particularly important feature that is studied by ecologists is the rate at which a population grows or...
07:24
Sonication Extraction of Lipid Biomarkers from Sediment
0 Views •
2023
Source: Laboratory of Jeff Salacup - University of Massachusetts Amherst The material comprising the living "organic" share of any ecosystem (leaves, fungi, bark, tissue; Figure 1) differs fundamentally from the material of the non-living "inorganic" share (rocks and their constituent minerals, oxygen, water, metals). Organic material contains carbon linked to a series of other carbon and hydrogen molecules (Figure 2), which distinguishes it from inorganic material. Carbon's wide valency range...
01:20
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
0 Views •
2025
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging. The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include: Troponins Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
FAQs
They compare biomarker distributions within and between populations rather than relying on a single measurement or group average. Researchers examine how results relate to demographic, environmental, genetic, and clinical factors while accounting for variation among individuals and groups. This approach helps identify patterns linked with disease, exposure, risk, treatment response, or health outcomes without treating every difference as clinically meaningful.
Representative sampling helps ensure that measured biomarker patterns reflect the population under investigation rather than the characteristics of a narrowly selected group. It is especially important when researchers evaluate differences associated with demographic, environmental, genetic, or clinical factors. Without careful sampling, comparisons may be difficult to interpret and findings may be less useful for assessing biomarker performance across diverse populations.
Standardized assays make measurements more consistent across participants and study groups, supporting meaningful comparison of biomarker distributions. Validation then tests whether observed associations provide reliable insight rather than appearing only in one investigation or setting. Together, these practices strengthen evidence for potential screening, prognostic, or treatment-selection markers and support the careful translation of research findings into clinical insight.
Researchers may collect biospecimens or obtain clinical measurements, depending on the disease, exposure, risk factor, treatment response, or health outcome under investigation. The selected material or measurement must support a standardized assay and statistical comparison across participants. Combining biomarker results with demographic, environmental, genetic, or clinical information allows investigators to evaluate relevant population patterns.
These studies can identify candidate biomarkers whose distributions or associations correspond with disease, risk, treatment response, or health outcomes. Researchers then assess whether the markers provide useful evidence for screening, estimating prognosis, or selecting treatment. Because a population-level association does not automatically establish clinical reliability, validation and careful interpretation are necessary before translating a candidate marker into clinical insight.
Biomarker performance may be interpreted differently when demographic, environmental, genetic, or clinical characteristics vary between groups. Evaluating diverse populations helps determine whether an observed association is consistent across relevant populations and supports more reliable clinical insight. This work also connects individual biomarker research with population health research by examining how biological indicators relate to outcomes across groups.